ICN Pharmaceuticals Inc., a Costa Mesa drug maker and distributor, said it has bought 225,000 shares of its Viratek Inc. subsidiary from the Eastman Kodak Co., ending Kodak's association with the company. The privately negotiated transaction was valued at about $2.4 million.
The sale, approved last week, called for ICN to buy the shares from Kodak at $10.50 each, the price of the stock the day the deal was approved late last week. Viratek closed Monday at $13.25 per share in over-the-counter trading.
